General Range
FORDOXIME-100 Dry Syrup
Price on request/100 · MOQ 100 boxes
FORDOXIME-100 Dry Syrup by Fortune Labs contains Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic used to treat selected bacterial infections. Cefpodoxime works by inhibiting bacterial cell wall synthesis, helping eliminate susceptible infection-causing bacteria. FORDOXIME-100 may be prescribed for respiratory tract infections, ear infections, throat infections, urinary tract infections, and certain skin infections when clinically appropriate. Its oral suspension formulation provides a convenient administration option for pediatric patients under medical supervision. Available in 30 ml packaging with water for reconstitution, FORDOXIME-100 is part of Fortune Labs' pediatric pharmaceutical range. Fortune Labs offers Pediatric PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, and franchise enquiries. Use only as prescribed.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefpodoxime Proxetil Oral Suspension IP (15 mg/30 ml as visible on packaging; verify strength on label)
- Packaging Type
- Dry Syrup Bottle with Outer Carton and Sterile Water for Reconstitution
- Packaging Size
- 30 ml
- Dosage Form
- Oral Suspension
- Treatment
- Bacterial respiratory tract infections, throat infections, ear infections, sinusitis, urinary tract infections, and certain skin infections caused by
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
